NonmucoidPseudomonas aeruginosaExpresses Alginate in the Lungs of Patients with Cystic Fibrosis and in a Mouse Model
Open Access
- 1 August 2005
- journal article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 192 (3), 410-419
- https://doi.org/10.1086/431516
Abstract
BackgroundIn patients with cystic fibrosis (CF), lung infection with mucoid Pseudomonas aeruginosa strains overexpressing the exopolysaccaride alginaKeywords
This publication has 28 references indexed in Scilit:
- Longitudinal Development of Mucoid Pseudomonas aeruginosa Infection and Lung Disease Progression in Children With Cystic FibrosisJAMA, 2005
- Human Monoclonal Antibodies toPseudomonas aeruginosaAlginate That Protect against Infection by Both Mucoid and Nonmucoid StrainsThe Journal of Immunology, 2004
- Relevance of animal models for chronic bacterial airway infections in humans.American Journal of Respiratory and Critical Care Medicine, 1995
- [22] Isolation and assay of Pseudomonas aeruginosa alginateMethods in Enzymology, 1994
- Mechanism of conversion to mucoidy in Pseudomonas aeruginosa infecting cystic fibrosis patients.Proceedings of the National Academy of Sciences, 1993
- Differentiation of Pseudomonas aeruginosa into the alginate‐producing form: inactivation of mucB causes conversion to mucoidyMolecular Microbiology, 1993
- Role of alginate in infection with mucoid Pseudomonas aeruginosa in cystic fibrosis.Thorax, 1992
- A Mouse Model of Chronic Pulmonary Infection with Pseudomonas aeruginosa and Pseudomonas cepaciaPediatric Research, 1987
- Alginate production by clinical nonmucoid Pseudomonas aeruginosa strainsJournal of Clinical Microbiology, 1987
- RAT MODEL OF CHRONIC RESPIRATORY-INFECTION WITH PSEUDOMONAS-AERUGINOSAPublished by Elsevier ,1979